OptiNose (United States)

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

• Neuroscience 6.5×
• Pharmacology, Toxicology and Pharmaceutics 5.6×
• Medicine 4.5×
• Dentistry 2.6×

Ranked on the composite score, Ramy Mahmoud and John Messina lead among researchers whose main affiliation is OptiNose (United States).

1. 1 🇺🇸 Ramy Mahmoud United States · #402,712 worldwide 77 citations · 21 works
2. 2 🇺🇸 John Messina United States · #1,339,348 worldwide 17 citations · 18 works

By fractional works in all years, weighted toward what it does more of than the world: Quality of Life, Inflammation, Endoscopic Surgery, Chronic Rhinosinusitis, Nasal Polyps, Asthma, Epidemiology and Allergen-specific Immunotherapy.

By volume in 2022–2025: Sinusitis and nasal conditions, Respiratory and Cough-Related Research, Allergic Rhinitis and Sensitization and Cystic Fibrosis Research Advances.

1. 1 Sinusitis and nasal conditions Otorhinolaryngology 1 works
2. 2 Respiratory and Cough-Related Research Pulmonary and Respiratory Medicine 0 works
3. 3 Allergic Rhinitis and Sensitization Immunology and Allergy 0 works
4. 4 Cystic Fibrosis Research Advances Pulmonary and Respiratory Medicine 0 works
5. 5 Olfactory and Sensory Function Studies Sensory Systems 0 works
6. 6 Nasal Surgery and Airway Studies Surgery 0 works
7. 7 Inhalation and Respiratory Drug Delivery Pulmonary and Respiratory Medicine 0 works
8. 8 Dental Anxiety and Anesthesia Techniques Oral Surgery 0 works
9. 9 Advanced Drug Delivery Systems Pharmaceutical Science 0 works

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

Output in 2018–2022 was 108% higher than in 2013–2017.

• Huntsworth Health (United States)
• NeuroDx Development (United States)